Anna B Mitchell1, Tenley E Ryan2, Amanda R Gillion2, Lindsey D Wells2, Muthiah P Muthiah3. 1. Veterans Affairs Medical Center (VAMC), Memphis, Tenn. Electronic address: Anna.Mitchell2@va.gov. 2. Veterans Affairs Medical Center (VAMC), Memphis, Tenn. 3. Veterans Affairs Medical Center (VAMC), Memphis, Tenn; University of Tennessee Health Science Center, Memphis.
Abstract
BACKGROUND: Sepsis and septic shock are medical emergencies resulting in significant morbidity and mortality. Intravenous (IV) vitamin C, thiamine, and hydrocortisone have shown promise in reducing hospital mortality. The Memphis Veterans Affairs Medical Center (VAMC) similarly implemented this regimen, called the vitamin C protocol, for patients presenting in sepsis or septic shock in the intensive care unit (ICU). METHODS: This retrospective study in Veteran ICU patients with sepsis or septic shock compared outcomes of patients treated with IV vitamin C, thiamine, and hydrocortisone (treatment) with those who received IV hydrocortisone alone (control). Data was propensity matched to ensure comparability at baseline. The Sequential Organ Failure Assessment (SOFA) score was calculated at day of diagnosis (day 0) and daily for 3 subsequent days. At the 24-month follow-up, 12 months after the 1-year-intervention, survival and measures of mental and physical health were collected by telephone interviews. RESULTS: Hospital mortality, the primary outcome, did not differ significantly between groups. Secondary outcomes including ICU, 28-day, and 60-day mortality were also not different, nor were vasopressor duration or hospital length of stay. However, ICU length of stay was significantly reduced in the treatment group compared to control (7.1 vs 15.6 days, respectively, P = 0.04). CONCLUSIONS: Although no significant mortality benefit was observed, the vitamin C protocol was not associated with patient harm. In this Veteran population, there was reduced ICU length of stay, suggesting possible benefit. Though further investigation is warranted, utilization of IV vitamin C, thiamine, and hydrocortisone in patients with sepsis or septic shock may be a treatment option worth considering. Published by Elsevier Inc.
BACKGROUND:Sepsis and septic shock are medical emergencies resulting in significant morbidity and mortality. Intravenous (IV) vitamin C, thiamine, and hydrocortisone have shown promise in reducing hospital mortality. The Memphis Veterans Affairs Medical Center (VAMC) similarly implemented this regimen, called the vitamin C protocol, for patients presenting in sepsis or septic shock in the intensive care unit (ICU). METHODS: This retrospective study in Veteran ICU patients with sepsis or septic shock compared outcomes of patients treated with IV vitamin C, thiamine, and hydrocortisone (treatment) with those who received IV hydrocortisone alone (control). Data was propensity matched to ensure comparability at baseline. The Sequential Organ Failure Assessment (SOFA) score was calculated at day of diagnosis (day 0) and daily for 3 subsequent days. At the 24-month follow-up, 12 months after the 1-year-intervention, survival and measures of mental and physical health were collected by telephone interviews. RESULTS: Hospital mortality, the primary outcome, did not differ significantly between groups. Secondary outcomes including ICU, 28-day, and 60-day mortality were also not different, nor were vasopressor duration or hospital length of stay. However, ICU length of stay was significantly reduced in the treatment group compared to control (7.1 vs 15.6 days, respectively, P = 0.04). CONCLUSIONS: Although no significant mortality benefit was observed, the vitamin C protocol was not associated with patient harm. In this Veteran population, there was reduced ICU length of stay, suggesting possible benefit. Though further investigation is warranted, utilization of IV vitamin C, thiamine, and hydrocortisone in patients with sepsis or septic shock may be a treatment option worth considering. Published by Elsevier Inc.
Entities:
Keywords:
Hydrocortisone; ICU; Sepsis; Septic shock; Thiamine; Veteran; Vitamin C
Authors: Leland Shapiro; Sias Scherger; Carlos Franco-Paredes; Amal A Gharamti; David Fraulino; Andrés F Henao-Martinez Journal: Front Pharmacol Date: 2022-06-23 Impact factor: 5.988
Authors: Sander Rozemeijer; Harm-Jan de Grooth; Paul W G Elbers; Armand R J Girbes; Corstiaan A den Uil; Eric A Dubois; Evert-Jan Wils; Thijs C D Rettig; Arthur R H van Zanten; Roel Vink; Bas van den Bogaard; Rob J Bosman; Heleen M Oudemans-van Straaten; Angélique M E de Man Journal: Trials Date: 2021-08-18 Impact factor: 2.279
Authors: Sean S Scholz; Rainer Borgstedt; Nicole Ebeling; Leoni C Menzel; Gerrit Jansen; Sebastian Rehberg Journal: Crit Care Date: 2021-01-06 Impact factor: 9.097